Back to All Events

8th Annual Biologics Symposium, London


Join us at the Annual Biologics Symposium to discuss the latest advances in the biologics field

The Annual Biologics Symposium is back for its eighth year, and we're confident that 2018 is going to be our most inspiring year yet!

This two day educational event brings together peers from across the biologics community to share information and discuss real life research, techniques and challenges in biological drug development.

 

Confirmed speakers

We are delighted to have the following speakers confirmed for the symposium:

Dr. Richard Sainson - Director in Pharmacology and Translational Sciences, Kymab Ltd

KY1044, a novel anti-ICOS antibody, elicits long term in vivo anti-tumour efficacy as monotherapy or in combination with immune checkpoint inhibitors

Dr. Mark Aspinall-O'Dea - EMEA Business Development Manager, Retrogenix Ltd

Identifying critical target receptors and assessing specificity of biologics using cell microarray technology

Dr. Rocky Cranenburgh - Chief Scientific Officer, Prokarium Ltd

The Vaxonella platform for oral vaccine delivery using Salmonella

Dr. Katja Fiedler - Scientist, CureVac

Intratumoral RNA therapy for solid tumors

Dr. Tomáš Hanke - Professor in Vaccine Immunology, University of Oxford

HIV-1 Vaccines: Dealing with Diversity

Dr. Anne Goubier - VP Immunology, Tusk Therapeutics

Targeting CD38 beyond haematological malignancies: a panel of anti-CD38 antibodies with unique functional properties

Dr. Armin Sepp - Systems Modeling and Translational Biology, GSK

Predictive Physiologically-Based Pharmacokinetics (PBPK) for Biologics

Vasanthi Mowat - Director of Pathology, Envigo

Interpreting histopathology challenges with biologics: background, immune-mediated or pharmacology?

Dr. Jonathan Hare - Senior Manager, Vaccine Design & Development, IAVI

How understanding the host-pathogen relationship can contribute to rationale HIV CD-8 T-cell vaccine design (and beyond)

Dr. Fiona Sewell - Programme Manager in Toxicology and Regulatory Sciences, NC3Rs

Are we fully exploiting the use of a single species for post-‘First-in-Human’ (FIH) studies allowed within ICHS6?

Dr Keith Martin - CEO, Apitope

Apitopes® to treat the cause of autoimmune diseases: from concept to clinic

Dr. Neil Williams - Chief Scientific Officer/Founder, KWS BioTest

Title TBC

Daniel Rabbie - Regulatory Affairs Manager, Cell and Gene Therapy Catapult

Title TBC

 

The full agenda will be posted soon.

 

Why attend?

 

  • Scientific insights you can apply right away.Delegates will hear from industry experts presenting insightful, informed and thought-provoking scientific content through a series of keynotes, best practice and case study sessions.
  • Real questions answered by an industry expert.All presentations will be followed by a Q&A session ensuring delegates have the opportunity to have their real questions answered by an expert.
  • Engage in thought-provoking discussions. Previous attendees have commented on the events non-commercial atmosphere and ability to achieve a perfect mix of big pharma, industry, academia and small biotech delegates. With this in mind, we've made sure the agenda allows for ample networking opportunities.

100% of delegates from our past three annual events have said they would attend again, so what are you waiting for? Register today to secure your seat!

 

Venue

We’re delighted to be hosting the 2018 event at the IET London: Savoy Place, which has recently undergone a £30 million refurbishment. Located on the River Thames, we’re confident that this inspiring venue will help make the eighth Annual Biologics Symposium one to remember. Click here to explore the venue.

 

Networking event

Monday 1 October, 2018, 17:00 - 18:00 (straight after the closing remarks)

A chance to get together with fellow delegates and speakers to continue discussions and make new connections. Nibbles and drinks will be served in the Maxwell Library at the IET London: Savoy Place.

Questions, comments or suggestions?

Please get in touch, we'd love to hear from you. Our friendly events team can be reached via email: marketing@envigo.comor via phone +44 (0)1480 892038.